The Salk Institute for Biological Studies, Laboratory of Genetics, La Jolla, CA 92037, USA.
National Institutes of Health, National Institute of Diabetes and Digestive Diseases, Bethesda, MD 20892, USA.
Science. 2020 Feb 14;367(6479):810-814. doi: 10.1126/science.aay8015. Epub 2020 Jan 30.
The HIV intasome is a large nucleoprotein assembly that mediates the integration of a DNA copy of the viral genome into host chromatin. Intasomes are targeted by the latest generation of antiretroviral drugs, integrase strand-transfer inhibitors (INSTIs). Challenges associated with lentiviral intasome biochemistry have hindered high-resolution structural studies of how INSTIs bind to their native drug target. Here, we present high-resolution cryo-electron microscopy structures of HIV intasomes bound to the latest generation of INSTIs. These structures highlight how small changes in the integrase active site can have notable implications for drug binding and design and provide mechanistic insights into why a leading INSTI retains efficacy against a broad spectrum of drug-resistant variants. The data have implications for expanding effective treatments available for HIV-infected individuals.
HIV 整合酶三聚体是一种大型核蛋白组装体,介导病毒基因组的 DNA 拷贝整合到宿主染色质中。整合酶三聚体是最新一代抗逆转录病毒药物,即整合酶链转移抑制剂(INSTIs)的作用靶点。与慢病毒整合酶三聚体生物化学相关的挑战阻碍了对 INSTIs 与其天然药物靶标结合方式的高分辨率结构研究。在这里,我们展示了与最新一代 INSTIs 结合的 HIV 整合酶三聚体的高分辨率冷冻电镜结构。这些结构突出了整合酶活性位点的微小变化如何对药物结合和设计产生显著影响,并提供了对为什么一种领先的 INSTI 对广泛的耐药变体仍保持疗效的机制见解。这些数据对于扩大可供感染 HIV 的个体使用的有效治疗方法具有重要意义。